Divestiture

A new study finds traditional banks reject 93% of emergency loan seekers, pushing millions toward predatory lenders with 400%+ APR. Is fintech the answer?

A landmark lawsuit claims the city’s failure to regulate vendors has decimated a community market, threatening student scholarships and small businesses.

Tesla's Q4 report shows a complex picture. Vehicle deliveries fell short, but record-breaking growth in the energy division hints at a major strategic shift.

FHLBank Chicago is injecting $55 million in subsidies to help local lenders in IL & WI fund affordable housing and small businesses.

Lantheus sells its legacy SPECT business to fusion-tech firm SHINE, sharpening its focus on high-growth PET diagnostics and next-gen cancer therapies.

Bitcoin miner Bitfarms sells its last Latin American asset for $30M, pivoting fully to the booming North American AI and HPC infrastructure market.

Distressed debt giant Silver Point Capital acquires a controlling interest in claims against bankrupt auto parts maker First Brands, a strategic move.

Interim CFO Donna Granato's departure marks a pivotal moment for Ayr Wellness as it completes a massive debt restructuring and transitions to a new entity.

Hyatt finalizes a $2B asset sale to Tortuga Resorts, advancing its asset-light strategy while navigating hurricane recovery in the Caribbean.

From a huge 10-restaurant deal to stadium snacks, The ONE Group reveals a capital-efficient playbook for expanding its Benihana and STK brands.

After selling its Oklahoma assets, Amplify Energy has eliminated its debt and is now focusing its capital on high-potential Beta and Bairoil fields.

A Mississippi ER doctor launches a national award for student entrepreneurs, but the founder's own history includes a federal conviction and a pardon.

Branded Legacy just wiped out $1M in legacy debt. The move is part of a radical overhaul by new management aimed at rebuilding investor confidence.

Alico pivots from its 125-year citrus legacy to land development, and its CEO is set to face investors with a bold new plan for its 50,000 acres.

Setrusumab, a promising drug for Osteogenesis Imperfecta, failed to reduce fractures in key trials, triggering a market collapse and strategic overhaul.

With a promising schizophrenia drug stalled by FDA requirements and finances tight, Reviva Pharmaceuticals' upcoming presentation is more than just a talk.

Frontera's new prepayment pact with Chevron shores up its finances and locks in crude sales, highlighting a strategic win in a volatile oil market.

Gogo has launched its anticipated 5G network for business jets, promising a new era of speed. But can its regional advantage hold against global satellite rivals?

As its partnership with Rio Tinto's Nuton ends, Arizona Sonoran will independently advance its massive copper project, betting on strong economics.

Once a cannabis fund, WEDG has completed its rebrand to Nuclear Diamond Batteries, Inc., betting its future on a patented, decades-long power source.